Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Annual Meeting 2018

Spotlight on Clinical Trials 

The online abstract submitter is now closed to new submissions. Final data for placeholder abstracts are due Friday, Feb. 23, 2018.

Submit Your Clinical Trials Abstracts to the AACR Annual Meeting 2018
Become a part of our growing science-based clinical research program at the Annual Meeting and help us showcase how research continues to transform the lives of cancer patients.

  • Submit your completed or placeholder abstract(s) by the Jan. 24, 2018 extended deadline for clinical trials and late-breaking abstracts
  • Final results and conclusions for placeholder abstracts are due by Feb. 23, 2018.

Why Submit?

  • Numerous and unique oral presentation opportunities.
    • Four Clinical Trials Plenary Sessions offering companion presentations explaining the science behind the presented trials.
    • Three Clinical Trials Minisymposia.
  • Poster presentations.
  • Potential national media coverage through the extensive AACR press program.
  • Opportunities to simultaneously present your work and publish manuscript in a high-impact AACR journal.
    • If you will have a complete manuscript ready to submit by late January, select the appropriate options during the abstract submission process.
    • If accepted, your abstract and manuscript may be presented and published simultaneously, in addition to being included in the press program.
    • Email​ with any questions or to indicate your interest in submitting a manuscript.
  • No restrictions on presenters as long as the presentation is CME-compliant.

What to Submit

  • Any phase (I, II, III, or any combination) abstract from national or international clinical trials.
  • Promising ongoing trials or unique trial designs that have not yet yielded results to the Clinical Trials in Progress category (CT07).

Clinical Trials (Including Combination and Immunotherapy Trials) Abstract Categories

  • CT01 Phase I Adult Clinical Trials
    • See also ET05: Pharmacology, Pharmacogenetics, and Pharmacogenomics)
  • CT02 Phase II Adult Clinical Trials
  • CT03 Phase III Adult Clinical Trials
  • CT04 Phase I, II, or III Clinical Trials in Pediatric Cancer
    • (See also CL02: Pediatric Cancer - Clinical Investigations; TB08: Pediatric Cancer - Basic Science)
  • CT05 Phase I, II, or III Clinical Trials in the Elderly
  • CT06 Phase I, II, or III Clinical Trials in Minorities and Medically Underserved Populations
  • CT07 Clinical Trials in Progress
    • Phase I Clinical Trials
    • Phase II Clinical Trials
    • Phase III Clinical Trials


Top of page